Clinical Trials Logo

Clinical Trial Summary

Gastrografin is a radiopaque contrast agent for the gastrointestinal tract (GIT) which can be applied orally or rectally. In neonatal intensive care, Gastrografin is used to detect otherwise radiologically invisible perforations or an insufficient GIT anastomosis after surgery. Furthermore it is used for the treatment of meconium ileus. Gastrografin has a strong osmotic effect and leads to water influx into the intestine lumen. Thereby the peristaltic movement is accelerated and the premature infant excretes stool during the hours following application. Therefore Gastrografin might be effective to mobilize meconium from small bowel and deep parts of the colon. The investigators hypothesized that enteral application of Gastrografin accelerates meconium evacuation in premature infants, and thereby enhances feeding tolerance in this population.


Clinical Trial Description

In premature infants the establishment of proper gastrointestinal function is challenging and often associated with delayed meconium passage. Meconium evacuation depends on gestational age and birthweight: the more immature an infant is, the later meconium passage starts and the longer meconium passage lasts. The mean duration of meconium evacuation in premature infants with a gestational age below 30 weeks is 8 days, while mature infants excrete their meconium in 2 days. The obstruction of deep intestinal segments by tenacious, sticky meconium frequently leads to gastric residuals, a distended abdomen and delayed food passage. The time lag to full enteral feedings is extended, the probability to acquire infections due to intravenous access for parenteral nutrition increases and the hospital stay of the infant is prolonged. However, the relation between meconium passage and feeding tolerance remains controversial. While one study showed that there is little concordance between first meconium passage and feeding tolerance, an other one showed that rapid and complete excretion of meconium is crucial for oral feeding tolerance and has a positive effect on it. Recently, the investigators performed a prospective randomized trial to determine, whether repeated prophylactic applications of small volume glycerin enemas accelerate passage of meconium in very low birth weight (VLBW) infants. Disappointingly, application of enemas did not accelerate meconium evacuation. A possible reason for the ineffectiveness of glycerin enemas is that the volume used was too small to mobilize tenacious meconium sufficiently from the colon and small bowel.

Gastrografin is a radiopaque contrast agent for the gastrointestinal tract (GIT) which can be applied orally or rectally. In neonatal intensive care, Gastrografin is used to detect otherwise radiologically invisible perforations or an insufficient GIT anastomosis after surgery. Furthermore it is used for the treatment of meconium ileus. Gastrografin has a strong osmotic effect and leads to water influx into the intestine lumen. Thereby the peristaltic movement is accelerated and the premature infant excretes stool during the hours following application. Therefore Gastrografin might be more effective to mobilize meconium from small bowel and deep parts of the colon. The investigators hypothesized, that enteral application of Gastrografin accelerates meconium evacuation in premature infants, and thereby enhances feeding tolerance in this population. The objective of the present study is to determine whether the enteral application of the osmotic contrast agent Gastrografin® accelerates complete meconium excretion and improves feeding tolerance in very low birth weight infants. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01515696
Study type Interventional
Source Medical University of Vienna
Contact
Status Completed
Phase Phase 4
Start date October 2007
Completion date February 2011

See also
  Status Clinical Trial Phase
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Not yet recruiting NCT04041765 - IgM-Enriched Immunoglobulin for Neonatal Sepsis Phase 3
Completed NCT01683760 - Pharmacokinetic Study of Fluconazole in Premature Infants Phase 2
Completed NCT04282655 - Effect of Milk Warming on the Very Low Birth Weight Infant N/A
Active, not recruiting NCT05436925 - CGM Use in Preterm Infants
Recruiting NCT04497012 - Iron Supplementation and Intestinal Health Phase 4
Recruiting NCT05308134 - Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM) N/A
Completed NCT03682575 - Work of Breathing in Premature Infants at Discharge
Terminated NCT02987764 - Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants N/A
Completed NCT05686252 - RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants N/A
Not yet recruiting NCT05806684 - Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
Completed NCT03916159 - Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants N/A
Not yet recruiting NCT04640805 - Targeted Fortification of Pasteurized Donor Human Milk N/A
Completed NCT06200324 - Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newborns in Colombia 2017-2023
Completed NCT05022433 - Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
Not yet recruiting NCT03163212 - Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants Early Phase 1
Completed NCT00962754 - Fluid Balance Study in Sick Neonates Phase 4
Not yet recruiting NCT06433674 - Enteral Zinc Supplementation in Very Low Birth Weight Infants Phase 3
Recruiting NCT05961657 - USCOM Parameters in Preterm Infants: Reference Ranges
Completed NCT05406804 - Olfactory Stimulation for Very Low Birth Weight Infants N/A